Kenya Launches Lenacapavir: A Game-Changer in HIV Prevention

Kenya has made a significant stride in the fight against HIV by rolling out Lenacapavir, a long-acting preventive injection that offers protection for up to six months. This move positions Kenya among the pioneering nations to introduce this innovative therapy, which will be provided free of charge to qualifying patients.

New Hope for Kenyans Living with HIV

During the launch at Riruta Health Centre in Nairobi, Health Minister Aden Duale heralded this initiative as a beacon of hope for countless families in Kenya. With approximately 1.4 million individuals living with HIV in the country, this new prevention method is particularly critical, especially for vulnerable groups aged 15 to 24, who bear a disproportionate burden of the infection.

Duale remarked, “Today represents a moment of hope for thousands of Kenyan families. Many of our young people still face the risk of infection. This innovation gives us renewed strength in our national fight against HIV.” He assured that Lenacapavir would be made available free of charge at selected public health facilities across priority counties, including options for pregnant and breastfeeding mothers.

How Lenacapavir Works

Lenacapavir, referred to as LEN, is administered subcutaneously, typically in the lower abdomen or thigh, and requires only two injections per year. This long-acting injectable has already garnered attention, being named the ‘Breakthrough of the Year’ by Science magazine in 2024. The government has also established systems to monitor any side effects associated with the treatment, emphasizing safety and efficacy in its distribution.

The introduction of Lenacapavir comes as Kenya received an initial shipment of 21,000 doses through a partnership with Gilead Sciences and the Global Fund to Fight AIDS. A further allocation of 12,000 doses is anticipated by April, along with an additional 25,000 doses from the United States government.

Tackling a Growing Public Health Crisis

The deployment of Lenacapavir is not merely a medical advancement; it’s a vital public health response to a growing crisis. Kenya is witnessing thousands of new HIV infections each year. The government recognizes that expanding prevention options is essential to combat the virus and protect its most vulnerable populations.

Duale emphasized the need for innovative strategies, stating, “Expanding innovative prevention options is critical to reversing transmission trends.”

In comparison, other Southern African countries like South Africa, Eswatini, and Zambia began administering this injection in December 2025. Recently, Zimbabwe also launched Lenacapavir with the aim of reaching over 46,000 individuals at high risk of contracting HIV.

Community Focus and Future Outlook

While Kenya embarks on this new journey, the government has stressed the importance of community involvement and education regarding this treatment option. Health workers will play a crucial role in conveying the benefits of Lenacapavir to those at risk.

With governing bodies like the United States Food and Drug Administration (FDA) approving Lenacapavir in June 2025, and the World Health Organization (WHO) offering endorsement shortly afterward, there is widespread optimism surrounding its use. WHO guidelines were released during the 13th International AIDS Society Conference held in Kigali, Rwanda, further endorsing its potential impact on global health.

The rollout in Kenya could serve as a model for other nations grappling with high HIV rates. As the program progresses, the government is committed to ensuring that the ongoing assessment of Lenacapavir’s effectiveness and safety is prioritized. This proactive approach underscores the urgency of addressing public health concerns in innovative ways.

A New Chapter in HIV Prevention

Lenacapavir’s introduction to the Kenyan healthcare landscape symbolizes a new chapter in the fight against HIV. As the country navigates through old and new challenges, there is palpable hope that this injection will not only lower infection rates but will foster resilience in communities burdened by the ongoing HIV crisis.

The global community will be watching closely, as Kenya takes significant steps toward improving health outcomes for its citizens while offering a pathway for other countries to follow suit.

— Reported by Nexio News